Extendicare Inc. (TSE:EXE – Get Free Report) announced a monthly dividend on Monday, September 16th, Zacks reports. Shareholders of record on Monday, September 30th will be paid a dividend of 0.04 per share on Tuesday, October 15th. This represents a $0.48 annualized dividend and a yield of 5.17%. The ex-dividend date of this dividend is Monday, September 30th.
Extendicare Stock Down 1.3 %
TSE EXE opened at C$9.28 on Tuesday. The business’s fifty day simple moving average is C$8.07 and its 200-day simple moving average is C$7.62. The company has a quick ratio of 0.98, a current ratio of 0.60 and a debt-to-equity ratio of 305.80. The firm has a market cap of C$774.60 million, a PE ratio of 13.65 and a beta of 1.26. Extendicare has a 52 week low of C$5.75 and a 52 week high of C$9.48.
Extendicare (TSE:EXE – Get Free Report) last posted its earnings results on Monday, August 12th. The company reported C$0.29 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. The company had revenue of C$348.48 million for the quarter, compared to analyst estimates of C$360.20 million.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on EXE
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- Are Penny Stocks a Good Fit for Your Portfolio?
- Market Got It Wrong—Why Progress Software Deserves a Second Look
- What is MarketRank™? How to Use it
- PENN Entertainment Eyes ESPN BET to Score Big in 2024 NFL Season
- Upcoming IPO Stock Lockup Period, Explained
- Don’t Miss Out: NETGEAR’s Turnaround Signals Big Potential
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.